Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of A Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

To see complete record on, please visit this link

Id: NCT02356965

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: December 2014

Last Update: March 26, 2015

Lead Sponsor: iX Biopharma Ltd.

Brief Summary: The purpose of the study is to test two different doses of ketamine sub-lingual (under the tongue) wafer against placebo to see how effective the medication is to treat moderate to severe pain after wisdom tooth extraction.

  • Pain

Total execution time in seconds: 0.22049593925476